Literature DB >> 11585672

BRCA1-associated tumorigenesis: what have we learned from knockout mice?

S G Brodie1, C X Deng.   

Abstract

A series of allelic mutations in the tumor suppressor Brca1 have been created to study mechanisms underlying BRCA1-associated tumorigenesis. Brca1 is essential in maintaining genome integrity through its involvement in DNA damage repair, G(2)-M cell-cycle checkpoint and centrosome duplication. The loss of Brca1 is not sufficient for malignant transformation, rather, it triggers multiple genetic alterations, including the inactivation of p53 and activation of a number of oncogenes, that ultimately result in mammary tumorigenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11585672     DOI: 10.1016/s0168-9525(01)02451-9

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  25 in total

1.  Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.

Authors:  Purnima K Wagh; Glendon M Zinser; Jerilyn K Gray; Archana Shrestha; Susan E Waltz
Journal:  Endocrinology       Date:  2012-04-02       Impact factor: 4.736

2.  Classification of BRCA1 missense variants of unknown clinical significance.

Authors:  C M Phelan; V Dapic; B Tice; R Favis; E Kwan; F Barany; S Manoukian; P Radice; R B van der Luijt; B P M van Nesselrooij; G Chenevix-Trench; T Caldes; M de la Hoya; S Lindquist; S V Tavtigian; D Goldgar; A Borg; S A Narod; A N A Monteiro
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

Review 3.  BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.

Authors:  Edgar S Diaz-Cruz; Marina C Cabrera; Rebecca Nakles; Beth H Rutstein; Priscilla A Furth
Journal:  Breast Dis       Date:  2010

Review 4.  Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

Authors:  Elizabeth A Musgrove; Elizabeth A Davison; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.

Authors:  Patrick E Corsino; Bradley J Davis; Peter H Nørgaard; Nicole N Teoh Parker; Mary Law; William Dunn; Brian K Law
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

6.  Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.

Authors:  Ellen E McCarthy; Julide T Celebi; Richard Baer; Thomas Ludwig
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation.

Authors:  S Shabbeer; D Omer; D Berneman; O Weitzman; A Alpaugh; A Pietraszkiewicz; S Metsuyanim; A Shainskaya; M Z Papa; R I Yarden
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

8.  Conditional knockout of brca1/2 and p53 in mouse ovarian surface epithelium: do they play a role in ovarian carcinogenesis?

Authors:  Ki-Yon Kim; Dong Wook Park; Eui-Bae Jeung; Kyung-Chul Choi
Journal:  J Vet Sci       Date:  2010-12       Impact factor: 1.672

9.  53BP1 ablation rescues genomic instability in mice expressing 'RING-less' BRCA1.

Authors:  Minxing Li; Francesca Cole; Dharm S Patel; Sarah M Misenko; Joonyoung Her; Amy Malhowski; Ali Alhamza; Haiyan Zheng; Richard Baer; Thomas Ludwig; Maria Jasin; André Nussenzweig; Lourdes Serrano; Samuel F Bunting
Journal:  EMBO Rep       Date:  2016-09-26       Impact factor: 8.807

10.  Modulatory effects of alpha- and gamma-tocopherols on 4-hydroxyestradiol induced oxidative stresses in MCF-10A breast epithelial cells.

Authors:  Eun-Ju Lee; Seung-Yeon Oh; Mi-Kyung Kim; Sei Hyun Ahn; Byung Ho Son; Mi-Kyung Sung
Journal:  Nutr Res Pract       Date:  2009-09-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.